ic dementia. There were no significant differences in the proportion with DLB according to age bands and dementia severity groups. The revised criteria for a clinical diagnosis of DLB increased the proportion of probable DLB by 25% compared to the previous criteria. Conclusion: DLB is common in patients with mild dementia, and is the second most common type of dementia. The introduction of new clinical criteria for DLB leads to an increase in the proportion diagnosed with probable DLB.
The consensus criteria for DLB were first published in 1996 to improve diagnostic accuracy [7] . However, low sensitivity to detect DLB has been reported using these criteria [8] , and DLB is the most frequent dementia type misdiagnosed clinically, most often as AD [9] . Therefore, the criteria were recently revised in the 3rd DLB consortium paper by incorporating additional suggestive features such as REM sleep behavior disorder (RBD) and low dopamine transporter uptake in basal ganglia, and the use of formal and informant-based standardized assessment tools for the identification and quantification of core and suggestive features was recommended [1] .
Most previous studies have not employed detailed neuropsychological testing or standardized operationalized assessment for core criteria such as visual hallucination or fluctuating cognition. This is important, since visual hallucinations and visuospatial impairment are the symptoms that best differentiate between AD and DLB in mildly demented patients [10] . Similarly, wide variations in the proportion with cognitive fluctuations have been reported, from 13 to 85%, and low inter-rater reliability has been found [11] , which contributes to the low inter-rater reliability and sensitivity of the clinical diagnosis of DLB reported even among experienced clinicians [12] . The lack of standardized assessment instruments for the core clinical features of DLB may also have led to an underestimation of the proportion with DLB.
The aim of this study was to find the frequency of DLB in the referrals to all specialist outpatient clinics within a defined geographical area among people with a first-time diagnosis of mild (MMSE 6 20) dementia according to DSM-IV using the revised clinical criteria, employing standardized instruments and operationalized criteria to detect and define key clinical core and suggestive features of DLB and other types of dementia. A secondary aim was to examine how the revised criteria would compare with the previous clinical criteria for DLB.
Methods

Subjects
From March 2005 to March 2007, we screened all referrals to outpatient clinics in geriatric medicine and old age psychiatry in the counties of Rogaland and Hordaland in Western Norway for patients with a first time diagnosis of mild dementia. The 3 neurology outpatient clinics in the area were contacted and agreed to refer new dementia cases to one of the participating centers. Study clinicians and study nurses had participated in several training sessions before study start, and training sessions were repeated bi-annually during the whole study period.
The patient and caregiver were first seen by the study clinician, who performed a structured clinical interview of demographics, previous diseases, and drug history. The comprehensive assessment procedure included a clinical examination including physical, neurological, psychiatric, and neuropsychological examinations, and routine blood tests.
Ethical Issues
The study was approved by the regional ethics committee and the Norwegian authorities for collection of medical data and received financial support from the regional health authorities of western Norway, Helse-Vest. The patients provided written consent to participate in the study after the study procedures had been explained in detail to the patient and a caregiver, usually the spouse or offspring.
Dementia Diagnosis
The diagnosis of dementia was made according to DSM-IV. The diagnosis for Alzheimer's disease dementia was made according to The National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association [13] , vascular dementia (VaD) according to the National Institute of Neurological Diseases and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences criteria [14] , DLB according to the revised consensus criteria [1] and Parkinson disease with dementia (PDD) according to the recommendations from the movement disorder society task force [15] . We applied the Lund-Manchester criteria for frontotemporal dementia (FTD) [16] and the DSM-IV criteria for alcoholic dementia. Caregivers completed The Informant Questionnaire on Cognitive Decline in the Elderly (the IQCODE), a questionnaire shown to be a reliable and valid instrument to detect dementia [17] , and the clinician completed the Clinician Dementia Rating scale (CDR) [18] and the Hachinski ischemia scale [19] . Significant cerebrovascular disease (CVD) based on clinical and/or imaging without fulfilling criteria for VaD was recorded. Two of the authors (D.A. and A.R.) independently applied the diagnostic criteria. In cases of disagreement, and in patients fulfilling more than one set of operationalized diagnostic criteria, the final ascertainment was made based on consensus. In addition, based on the same assessment, the 1996 consensus criteria for a clinical diagnosis of probable DLB were also applied, and ultimately the proportion fulfilling the two set of criteria for DLB were compared.
Inclusion Criteria
Patients were diagnosed with dementia for the first time. To select patients with mild dementia only, all subjects were screened with the Mini-Mental State Examination (MMSE) and a minimal score of 20 was required for inclusion.
Exclusion Criteria
Patients without dementia or with acute delirium or confusion, terminal illness, recently diagnosed with a major somatic illness, previous bipolar disorder or psychotic disorder were excluded.
Assessment
A detailed and comprehensive battery of assessment instruments was employed, emphasizing instruments that have been standardized and validated to diagnose people with early dementia, including DLB, since mildly demented people are likely to pose particular diagnostic challenges.
Neuropsychiatric Assessment
The psychiatric assessment focused on key symptoms such as visual hallucinations and depression, and was based on the neuropsychiatric inventory (NPI). The NPI was specifically designed to assess psychiatric symptoms in subjects with dementia based on a structured interview of a caregiver [20] . In addition, patients and caregivers were asked whether visual hallucinations had ever occurred. The presence of recurrent and formed visual hallucinations was based on the NPI visual hallucinations item, the clinical interview and any comments in the medical record. Depression was rated using the Montgomery and Asberg Depression Rating Scale (MADRS) [21] , and a history of clinically relevant depression was asked for in the interview. Parkinsonism was rated using the UPDRS motor subscale [22] . A diagnosis of parkinsonism required two or more of the four cardinal symptoms (i.e. tremor, rigidity, bradykinesia and gait disturbance/postural instability. Marked neuroleptic sensitivity required evidence of both motor and cognitive worsening after treatment with an antipsychotic agent [23] . Fluctuating cognition was rated using the Clinician Assessment of Cognitive Fluctuations [24] or the Mayo Fluctuation Questionnaire [11] using the recommended cut-off scores, i.e. one example given from the last month from question (a) or (b) and a total score of 5 or more from the Clinician Fluctuation Scale or 3 or 4 features from the Mayo Fluctuation Questionnaire.
RBD was diagnosed if there was a history of recurrent nocturnal dream enactment behavior, and was explored by means of questions to the bed partner regarding duration of symptoms, injuries to patient or bed partner, dream content and whether the dream content would fit to the movements of the patient during sleep [25] . Activities of daily living were assessed using the Rapid Disability Rating Scale-2 [26] .
Neuropsychological Examination
A comprehensive battery of neuropsychological tests was administered by a trained study nurse to corroborate a history and/ or clinical signs of cognitive impairment. Validated and published norms were used.
Verbal Memory
The California Verbal Learning Test II [27] consists of a list of 16 words read 5 times and a distractor list, providing subscores of immediate and delayed recall, free recall, recognition and discrimination.
Language
The Boston Naming Test is a highly sensitive tool to identify naming deficits and impaired word retrieval capacities in a variety of neurodegenerative disorders. We used a 15-item version of the test [28] .
Visuospatial Abilities Two subtests from the Visual Object and Space Perception Battery [29] , the Cube and Silhouette tests, were used.
Executive Functions
We assessed three different aspects of executive functioning: Verbal fluency (categorical) was tested by asking the patients to generate as many names of animals as possible within 1 min [30] . The Trail Making Test A and B is as a measure of attention shift and psychomotor speed [30] , and the Stroop Color-Word Test is a test of selective attention, disinhibition and interference [31] .
Imaging
A structural MRI was performed in 185 cases, mainly to identify CVD and other structural lesions. In a subgroup of 26 patients, we acquired SPECT images of the striatum after injection of 123I FP-CIT [32] , and the primary dementia diagnosis was changed from possible DLB to probable DLB in 3 cases due to this examination according the revised DLB criteria.
Statistics
Analyses consisted of rates and proportions using 95% confidence intervals (CIs). Between-group comparisons were made using one-way ANOVA for parametric variables, with post-hoc comparisons using Scheffe tests, respectively, and 2 for categorical data. SPSS version 13 was used, and a p value of 0.05 was considered statistically significant.
Results
A total number of 657 subjects were screened during the 2-year inclusion period, of whom 196 fulfilled inclusion criteria and 461 were excluded. Reasons for exclusion were: not willing to participate 102, normal cognition 48, mild cognitive impairment 79, moderate to severe dementia 166, other neurological disorder 7, bipolar disorder or psychosis 11, delirium 4, new somatic disorder or terminal illness 14, depression and pseudo-dementia 24 and missing data on 6. Among the excluded cases with dementia, 91 were diagnosed with AD, 22 had DLB, 27 VaD, 6 mixed and 121 unspecified dementia, and 3, 2 and 2 had FTD, alcoholic dementia and PDD. Of those included, 97% were living in their homes, 57% were married and 43% were living alone. Demographic and clinical characteristics of the included subjects are shown in table 1 .
Distribution of Dementia Diagnosis
One hundred and three patients (52.6%, 95% CI 45.6-59.5) had probable and 25 (12.8%, 95% CI 8.1-17.4) possible AD, 31 (15.8%, 95% CI 10.7-20.9) had probable and 8 (4.1%, 95% CI 1.3-6.9) possible DLB, 11 (5.6%, 95% CI 2.4-8.8) had probable PDD, 5 (2.6%, 95% CI 0.3-4.8) had probable and 6 (3.1%, 95% CI 0.7-5.5) possible VaD, 4 (2.0%, 95% CI 0.1-4.0) had FTD and 3 (1.5%, 95% CI -0.2 to 3.3) had alcoholic dementia ( fig. 1 ). Eighteen subjects (9.2%) had significant CVD without fulfilling the criteria for probable or possible VaD, and were diagnosed as possible AD (n = 16) and probable DLB (n = 2). Kappa for a diagnosis of probable DLB versus non-DLB was 0.73.
Characteristics of the Dementia Groups
The characteristics of the diagnostic groups are shown in table 1 .
2 and one-way ANOVAs were run, combining DLB and PDD in one group, and FTD and alcoholic dementia in one due to the low numbers. Posthoc Scheffe tests were run when the main analysis was significant. The gender distribution differed significantly (p ! 0.001). Duration of disease differed among the groups, with AD having a shorter, DLB medium, and VaD longer disease duration (AD vs. DLB p = 0.033 and AD vs. VaD p = 0.000). Age, education and MMSE score did not differ between groups. The DLB/PDD had high- er UPDRS motor subscores than all the other groups (p ! 0.001), and higher NPI total (p = 0.009) and MADRS (p = 0.026) scores than the AD group. The proportion with AD decreased with higher age, whereas the reverse pattern was seen in DLB, but there were no significant differences in the distribution of diagnosis with age group ( fig. 1 ) or dementia severity based on the CDR scores ( fig. 2 ) .
Comparison of Revised and Old Clinical Criteria for DLB
To examine whether the proportion with DLB using the two sets of criteria would differ, the 1996 criteria were applied to the cohort. 25 (12.8%, 95% CI 8.1-17.4%) subjects fulfilled criteria for probable DLB using the 1996 criteria ( table 2 ). The revised criteria thus showed a 24% (95% CI 18.0-30.0) increase in the proportion with probable DLB, and a corresponding decrease in the number with possible DLB. The transition from possible to probable DLB using the revised criteria was due to RBD in 4 and a positive CIT SPECT in 2 cases.
Discussion
The proportion of patients with dementia who have DLB is not known. A referral sample of patients with mild dementia was recruited in the Rogaland and Hordaland counties in Western Norway. The frequency of probable DLB was 15.8%, rendering this the second most common diagnosis after AD. The proportion was similar across age groups and dementia severity.
Compared to the 1996 criteria, the proportion increased by 25%, the main difference being that some patients with possible DLB fulfilled probable DLB using the revised criteria. Thus, although these criteria were not applied independently, the findings suggest that the revised criteria are more sensitive than the previous version. This was mainly due to RBD being included in the revised criteria. In addition, a positive 123I FP-CIT SPECT contributed to the increased frequency of probable DLB, but this test was employed only in a minority of patients with suspected DLB. Cardiac scintigraphy with 123I MIBG, which has demonstrated a high sensitivity for DLB [33] , was not performed. A recent autopsy study showed that only a minority of patients with mild DLB exhibited one of the core features [10] . Thus, it is likely that a more widespread use of these tests would have increased the number of subjects fulfilling the revised criteria for clinical DLB, indicating that our result is probably an underestimate of the true proportion with DLB in the referral population.
Only patients referred to a dementia clinic were included in the current study. Because of the wide variation in symptom presentation, DLB patients are referred to psychiatric, geriatric or neurology clinics, and local referral practices may occur. Therefore, care was taken to include all referrals to the dementia clinics in the region, and all services from these specialties covering the geographical area were involved in the study. Referral biases To examine whether the proportion with DLB using the two sets of criteria would differ, the 1996 criteria were applied to the cohort. 25 (12.8%, 95% CI 8.1-17.4%) subjects fulfilled criteria for probable DLB using the 1996 criteria. The revised criteria thus showed a 24% (95% CI 18.0-30.0) increase in the proportion with probable DLB, and a corresponding decrease in the number with possible DLB. The transition from possible to probable DLB using the revised criteria was due to RBD in 4 and a positive CIT SPECT in 2 cases. are therefore unlikely to have influenced the observed diagnostic distribution in this study.
Patients with new-onset dementia who are not detected by the health care system or are treated by the GP only were not included. These patients may differ from those referred by exhibiting less psychiatric, neurological, or general medical problems, and thus it is possible that DLB patients are overrepresented in the referral population. It has been found that dementia patients in Norway who were referred to a dementia clinic were younger, but clinically quite similar compared to those who were not referred [34] . Nevertheless, a door-to-door survey of a total or random subset of a population is needed to estimate the true frequency of DLB. In such studies, the proportion of probable DLB in dementia has been reported to be 10.9% in the 65+ group [35] and 14.6% in the 75+ group [36] , comparable to our findings.
However, much lower prevalences have also been reported [37] . Prevalence studies must balance the need of assessing large populations with that of performing detailed evaluations of all identified individuals, frequently employing a two-stage diagnostic strategy, where a detailed clinical evaluation is restricted to those who score positive on a screening instrument. However, such screening measures may not adequately pick up DLB cases. For example, in two studies that report a proportion of DLB below 5% [6] , a low MMSE score was used to screen for possible dementia. Since executive and visuospatial functions are not adequately captured by the MMSE, this is not a good measure to screen for DLB, and thus will most likely underestimate the frequency of DLB. There are currently no widely accepted screening measures for DLB.
The features of DLB are often missed, even in specialist settings [38] , and not employing standardized diagnostic measures may underestimate the frequency of DLB. Many previous studies did not employ standardized instruments or operationally defined criteria to identify the core features of DLB [6] . We established a priori definitions for identifying symptoms such as parkinsonism, hallucinations, neuroleptic sensitivity, RBD and fluctuating attention using established and standardized instruments and/or operationalized criteria. It is possible that these criteria are too restrictive, leading to high specificity but at the cost of low sensitivity. More research is needed to establish the optimal criteria for identifying the key features of DLB, and also to see whether imaging methods such as dopamine transporter scan, and cardiac MIBG scanning, can improve the sensitivity of a diagnosis of DLB.
Although the revised criteria for a pathological diagnosis of DLB have been found to be associated with a clinical diagnosis of DLB [39] , the sensitivity and specificity of the revised clinical criteria for DLB have not yet been subject to autopsy validation, and thus the diagnostic accuracy in terms of predicting Lewy body pathology is not yet known. Accordingly, the proportion with a pathological diagnosis of DLB in this study remains unknown.
We found a low proportion with probable VaD applying the NINDS-AIREN criteria. Earlier studies have found these criteria to be restrictive [40] , and low prevalence rates have also been reported in other studies, on average 8-10% in Western clinic-based series of cognitively impaired elderly people [41] . A substantial group had CVD without fulfilling a diagnosis of VaD, and some of these patients were diagnosed as DLB. It has been suggested that in some patients with a clinical diagnosis of DLB, vascular changes are more important contributors to the clinical phenotype than cortical Lewy bodies [42] . However, other studies indicate that cortical Lewy bodies are common even in patients with CVD, and that in some patients DLB is misdiagnosed as VaD [8] . More studies are needed to further clarify the relationship between CVD and DLB.
